Showing results 5708 to 5727 of 14621
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2017 | Fetal middle cerebral artery Doppler to time second and subsequent transfusions in fetal red cell alloimmunisation: A randomised trial | Dodd, J.M.; Andersen, C.; Dickinson, J.; Kilby, M.; Windrim, R.; Ryan, G.; RCOG World Congress (20 Mar 2017 - 22 Mar 2017 : Cape Town, South Africa) |
| 2014 | Fetal programming in 2-year-old calving heifers: peri-conception and first trimester protein restriction alters fetal growth in a gender-specific manner | Copping, K.; Hoare, A.; Callaghan, M.; McMillen, I.; Rodgers, R.; Perry, V. |
| 2014 | Fetoscopic endoluminal tracheal occlusion (FETO) for congenital diaphragmatic hernia in Australia and New Zealand: are we willing, able, both or neither? | Cundy, T.; Gardener, G.; Andersen, C.; Kirby, C.; McBride, C.; Teague, W. |
| 2004 | Fever as a precipitant of idiopathic ventricular fibrillation in patients with normal hearts | Pasquie, J.; Sanders, P.; Hocini, M.; Hsu, L.; Scavee, C.; Jais, P.; Takahashi, Y.; Rotter, M.; Sacher, F.; Victor, J.; Clementy, J.; Haissaguerre, M. |
| 2017 | FGF-2 gene polymorphism in osteoporosis among Guangxi’s Zhuang Chinese | Bin, X.; Lin, C.; Huang, X.; Zhou, Q.; Wang, L.; Xian, C.J. |
| 2006 | Fibrillating areas isolated within the left atrium after radiofrequency linear catheter ablation | Rostock, T.; Rotter, M.; Sanders, P.; Jais, P.; Hocini, M.; Takahashi, Y.; Sacher, F.; Jonsson, A.; O'Neill, M.; Hsu, L.; Clementy, J.; Haissaguerre, M. |
| 2008 | Fibroblast growth factor receptor 2 phosphorylation on serine 779 couples to 14-3-3 and regulates cell survival and proliferation | Lonic, A.; Barry, E.; Quach, C.; Kobe, B.; Saunders, N.; Guthridge, M. |
| 2015 | Fibroblast-specific upregulation of Flightless I impairs wound healing | Turner, C.; Waters, J.; Jackson, J.; Arkell, R.; Cowin, A. |
| 2017 | Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts | Smith, E.; Palethorpe, H.; Hayden, A.; Young, J.; Underwood, T.; Drew, P. |
| 2010 | Fibrodysplasia ossificans progressiva presenting as ankylosing spondylitis | Dugar, M.; Limaye, V.; Cleland, L.; Ahern, M. |
| 2008 | Fibrosis and cirrhosis reversibility - molecular mechanisms | Gieling, R.; Burt, A.; Mann, D. |
| 2017 | Fibrosis evaluation by transient elastography in alcoholic liver disease: is the histological scoring system impacting cutoff values? | Lackner, C.; Bataller, R.; Burt, A.; Miquel, R.; Schuppan, D.; Tiniakos, D.; Trauner, M. |
| 2015 | Fibrosis, gene expression and orbital inflammatory disease | Rosenbaum, J.; Choi, D.; Wilson, D.; Grossniklaus, H.; Harrington, C.; Dailey, R.; Ng, J.; Steele, E.; Czyz, C.; Foster, J.; Tse, D.; Alabiad, C.; Dubovy, S.; Parekh, P.; Harris, G.; Kazim, M.; Patel, P.; White, V.; Dolman, P.; Edward, D.; et al. |
| 2023 | Fibulin-3 is necessary to prevent cardiac rupture following myocardial infarction | Murtha, L.A.; Hardy, S.A.; Mabotuwana, N.S.; Bigland, M.J.; Bailey, T.; Raguram, K.; Liu, S.; Ngo, D.T.; Sverdlov, A.L.; Tomin, T.; Birner-Gruenberger, R.; Hume, R.D.; Iismaa, S.E.; Humphreys, D.T.; Patrick, R.; Chong, J.J.H.; Lee, R.J.; Harvey, R.P.; Graham, R.M.; Rainer, P.P.; et al. |
| 2019 | Fifty years of reproductive biology in Australia: highlights from the 50th Annual Meeting of the Society for Reproductive Biology (SRB) | Bromfield, E.G.; Dowland, S.N.; Dunleavy, J.E.M.; Dunning, K.R.; Holland, O.J.; Houston, B.J.; Pankhurst, M.W.; Richani, D.; Riepsamen, A.H.; Rose, R.; Bertoldo, M.J. |
| 2016 | Fighting sinus-derived Staphylococcus aureus biofilms in vitro with a bacteriophage-derived muralytic enzyme | Drilling, A.; Cooksley, C.; Chan, C.; Wormald, P.; Vreugde, S. |
| 2016 | Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: a Randomized Canadian Blood and Marrow Transplant Group Study | Couban, S.; Aljurf, M.; Lachance, S.; Walker, I.; Toze, C.; Rubinger, M.; Lipton, J.H.; Lee, S.J.; Szer, R.; Doocey, R.; Lewis, I.D.; Huebsch, L.; Howson-Jan, K.; Lalancette, M.; Almohareb, F.; Chaudhri, N.; Ivison, S.; Broady, R.; Levings, M.; Fairclough, D.; et al. |
| 2015 | Filtering the truth behind cerebral embolization during transcatheter aortic valve replacement | Rodés-Cabau, J.; Puri, R. |
| 2016 | Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer | Price, T.; Kim, T.W.; Li, J.; Cascinu, S.; Ruff, P.; Suresh, A.S.; Thomas, A.; Tjulandin, S.; Guan, X.; Peeters, M. |
| 2014 | Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer | Peeters, M.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; Andre, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; Tian, Y.; Sidhu, R. |
